These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 4139679)
21. [Current views on the epidemiology, etiology and pathogenesis of the rheumatic disease]. Marcolongo R; Di Paolo N; Bianco G Omnia Med Ther; 1970; 48(4):507-69. PubMed ID: 5315373 [No Abstract] [Full Text] [Related]
22. [The value of serologic tests in rheumatology]. Ebert H Z Arztl Fortbild (Jena); 1982 Dec; 76(23):977-8. PubMed ID: 6984989 [No Abstract] [Full Text] [Related]
23. [Interferons and other cytokines in rheumatic diseases]. Ospel'nikova TP; Egorova ON; Balabanova RM; Kozina VI; Ershov FI Vestn Ross Akad Med Nauk; 2010; (7):3-7. PubMed ID: 20799405 [TBL] [Abstract][Full Text] [Related]
24. Immune mechanisms in rheumatic disease. Workman ML Nurs Clin North Am; 2000 Mar; 35(1):175-88. PubMed ID: 10673573 [TBL] [Abstract][Full Text] [Related]
25. [Cellular immunity in rheumatic diseases]. Tannenbaum H Union Med Can; 1976 Apr; 105(4):523-7. PubMed ID: 1087056 [No Abstract] [Full Text] [Related]
26. [Basic immunologic indices and their significance in the diagnosis of rheumatic diseases. II. Analysis of immunologic indices in individual rheumatic diseases]. Timofeev VT Revmatologiia (Mosk); 1983; (4):48-54. PubMed ID: 6366975 [No Abstract] [Full Text] [Related]
27. Auto-immunity and the rheumatic diseases. McCormick JN Practitioner; 1967 Aug; 199(190):150-6. PubMed ID: 5299311 [No Abstract] [Full Text] [Related]
28. Clinical aspects of immune neuroendocrine mechanisms in rheumatic diseases. Bijlsma JW; Cutolo M; Straub RH; Masi AT Rheum Dis Clin North Am; 2005 Feb; 31(1):xiii-xvi. PubMed ID: 15639051 [No Abstract] [Full Text] [Related]
29. Hypersensitivity and infection in the pathogenesis of the rheumatic diseases. Walton KW Int Rev Exp Pathol; 1968; 6():285-374. PubMed ID: 4192074 [No Abstract] [Full Text] [Related]
30. [In which rheumatologic diseases is the immunologic etiology of importance?]. Lenoch F Z Gesamte Inn Med; 1969 May; 24(9):136-9. PubMed ID: 5306827 [No Abstract] [Full Text] [Related]
32. [Clinical and experimental study on the mode of correlation between rheumatic disease and ABO blood groups]. Bonvini E; Rosaschino F Minerva Pediatr; 1968 May; 20(18):929-39. PubMed ID: 5309001 [No Abstract] [Full Text] [Related]
33. Tissue injury induced by immune complexes--the most important pathogenical mechanism of collagen and rheumatic diseases. Popescu E Roum Arch Microbiol Immunol; 1993; 52(3):145-8. PubMed ID: 7833527 [No Abstract] [Full Text] [Related]
34. [The pathogenesis of rheumatic diseases. Role of infections]. Krause A; Baerwald C Internist (Berl); 1993 Sep; 34(9):806-16. PubMed ID: 8407198 [No Abstract] [Full Text] [Related]
35. [Modern concepts of the pathogenesis of rheumatism]. Anokhin VN; Novikov IuI; Stulova MA Vopr Revm; 1980; (2):3-7. PubMed ID: 6996324 [No Abstract] [Full Text] [Related]
36. The role of collagens in rheumatic diseases. Solinger AM; Hess EV J Rheumatol; 1982; 9(4):491-3. PubMed ID: 6182290 [No Abstract] [Full Text] [Related]
38. T cell epitope-specific immune therapy for rheumatic diseases. Albani S; Prakken B Arthritis Rheum; 2006 Jan; 54(1):19-25. PubMed ID: 16385493 [No Abstract] [Full Text] [Related]
39. Are we at a stage to predict autoimmune rheumatic diseases? Bizzaro N; Tozzoli R; Shoenfeld Y Arthritis Rheum; 2007 Jun; 56(6):1736-44. PubMed ID: 17530702 [No Abstract] [Full Text] [Related]
40. [Rheumatic manifestations in 50 cases of active chronic hepatitis]. Bistué R; de Carena CS; Scognamillo CD; Martínez L; de Prieto MP Medicina (B Aires); 1981; 41(4):401-6. PubMed ID: 6175881 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]